Translate page

Jeff LiptonToday we are pleased to share with you an expert opinion on interferon and CML during the COVID-19 pandemic by Professor Jeff Lipton from the Princess Margaret Hospital in Toronto, Canada.

You will find this and other expert opinions on the iCMLf COVID-19 hub that will continously be updated with recent information on COVID-19 and CML.

Please read the full expert opinion below. 

FirstTestThe iCMLf Diagnosis and Testing Program offers seeding grants to hematology institutions in emerging economic regions. The aim of the program is to facilitate the diagnosis, testing and long-term disease monitoring of CML patients in emerging economic regions where it is either limited, or not currently available.

Over six years the iCMLf have awarded 48 grants to enable CML diagnostics to be expanded and enhanced at a local level. This gives both physicians and patients the knowledge to make meaningful decisions on treatment. In 2018 the Foundation will offer 10 grants with funding of up to $10,000.

Applications will close on the 30th of July 2018. Proposals are welcome to
Read more for further information on how to apply.